Analysis of Telomerase-Independence Telomere Maintenance
端粒酶非依赖性端粒维持分析
基本信息
- 批准号:6918606
- 负责人:
- 金额:$ 28.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-15 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to characterize the mechanism of telomerase-independent telomere maintenance. Although telomerase activation is the most common mechanism for maintenance of telomeric DNA, a subset of tumors and cell lines use a telomerase-independent mechanism, termed Alternative Lengthening of Telomeres (ALT), to sustain telomeric DNA. In telomerase-deficient yeast strains, telomere stabilization is achieved through recombination-based mechanisms. Similarly, although the molecular mechanism has yet to be established, the evidence from mammalian systems is consistent with ALT involving recombination. Based on data from yeast studies, it has been suggested that telomere recombination requires loss of the capping activity by which telomeres were originally defined. To test this hypothesis in mammalian cells, the structure of ALT telomeres will be determined using molecular biological methods and electron microscopy. Clarifying the structure of ALT telomeres will provide insight into the molecular mechanism of ALT. Secondly, factors involved in DNA recombination that are essential for telomere maintenance by ALT will be identified using dominant negative and knockdown approaches. These data will characterize the molecular requirements for ALT and will differentiate between possible recombination-based mechanisms. The only genetic alteration in mammalian cells linked to a predisposition to activate ALT is p53 status. Among its other functions, p53 has been shown to be involved in suppression of recombination. Thus, the role of p53 in regulating ALT will be characterized using temperature sensitive alleles of p53. These data will be the first that illustrate how alterations in a factor might predispose cells to ALT. Inhibition of telomerase has become an attractive target for future chemotherapeutic agents. However, ALT tumors would be refractory to these treatments. This proposal will identify structural changes and factors essential for activation of ALT and thus identify new potential targets for chemotherapeutic agents.
描述(由申请方提供):本提案的目的是表征非端粒酶依赖性端粒维持的机制。虽然端粒酶激活是维持端粒DNA的最常见机制,但一部分肿瘤和细胞系使用称为端粒替代延长(ALT)的端粒非依赖性机制来维持端粒DNA。在端粒酶缺陷的酵母菌株中,端粒稳定化是通过基于重组的机制实现的。同样,尽管分子机制尚未确定,但哺乳动物系统的证据与ALT涉及重组一致。基于酵母研究的数据,已经表明端粒重组需要失去最初定义端粒的加帽活性。为了在哺乳动物细胞中验证这一假设,将使用分子生物学方法和电子显微镜来确定ALT端粒的结构。阐明ALT端粒的结构将有助于深入了解ALT的分子机制。其次,将使用显性阴性和敲低方法鉴定参与DNA重组的ALT维持端粒所必需的因子。这些数据将表征ALT的分子要求,并将区分可能的基于重组的机制。哺乳动物细胞中与激活ALT的倾向相关的唯一遗传改变是p53状态。在其其他功能中,p53已被证明参与抑制重组。因此,p53在调节ALT中的作用将使用p53的温度敏感等位基因来表征。这些数据将是第一个说明一个因素的改变如何使细胞易患ALT的数据。端粒酶的抑制已经成为未来化疗药物的一个有吸引力的靶点。然而,ALT肿瘤对这些治疗是难治的。该提案将确定ALT激活所必需的结构变化和因子,从而确定化疗药物的新的潜在靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOMINIQUE BROCCOLI其他文献
DOMINIQUE BROCCOLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOMINIQUE BROCCOLI', 18)}}的其他基金
Mechanistic analysis of the role of extrachromosomal telomeric circles in the ALT
染色体外端粒环在 ALT 中的作用机制分析
- 批准号:
8755484 - 财政年份:2014
- 资助金额:
$ 28.1万 - 项目类别:
Mechanistic analysis of the role of extrachromosomal telomeric circles in the ALT
染色体外端粒环在 ALT 中的作用机制分析
- 批准号:
8897311 - 财政年份:2014
- 资助金额:
$ 28.1万 - 项目类别:
Analysis of Telomerase-Independence Telomere Maintenance
端粒酶非依赖性端粒维持分析
- 批准号:
6678732 - 财政年份:2003
- 资助金额:
$ 28.1万 - 项目类别:
Analysis of Telomerase-Independence Telomere Maintenance
端粒酶非依赖性端粒维持分析
- 批准号:
7405168 - 财政年份:2003
- 资助金额:
$ 28.1万 - 项目类别:
Analysis of Telomerase-Independence Telomere Maintenance
端粒酶非依赖性端粒维持分析
- 批准号:
6784674 - 财政年份:2003
- 资助金额:
$ 28.1万 - 项目类别:
Analysis of Telomerase-Independence Telomere Maintenance
端粒酶非依赖性端粒维持分析
- 批准号:
7095128 - 财政年份:2003
- 资助金额:
$ 28.1万 - 项目类别:
相似国自然基金
RKTG对ERK信号通路的调控和肿瘤生成的影响
- 批准号:30830037
- 批准年份:2008
- 资助金额:190.0 万元
- 项目类别:重点项目
相似海外基金
Research on carcinogenesis and cell differentiation using established human pancreatic acinar cell carcinoma cell line
利用已建立的人胰腺腺泡细胞癌细胞系进行癌发生和细胞分化的研究
- 批准号:
19K07518 - 财政年份:2019
- 资助金额:
$ 28.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the epigenetic mechanism of arsenic carcinogenesis on human liver cancer cell line
砷致癌人肝癌细胞系的表观遗传机制研究
- 批准号:
23790680 - 财政年份:2011
- 资助金额:
$ 28.1万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Carcinogenesis caused by tobacco and alcohol for human tongue keratinocytes (HTK) cell line
烟草和酒精对人舌角质形成细胞(HTK)细胞系的致癌作用
- 批准号:
21890287 - 财政年份:2009
- 资助金额:
$ 28.1万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
2738814 - 财政年份:1999
- 资助金额:
$ 28.1万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6133912 - 财政年份:1999
- 资助金额:
$ 28.1万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6499423 - 财政年份:1999
- 资助金额:
$ 28.1万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6629306 - 财政年份:1999
- 资助金额:
$ 28.1万 - 项目类别:
MOLECULAR BASIS AND USE OF A RADIAL GLIA CELL LINE C6-R
放射状胶质细胞系 C6-R 的分子基础和用途
- 批准号:
6351871 - 财政年份:1999
- 资助金额:
$ 28.1万 - 项目类别:
Analyses of a Non tumorigenic Teratocarcinoma Cell Line
非致瘤性畸胎癌细胞系的分析
- 批准号:
6512638 - 财政年份:1990
- 资助金额:
$ 28.1万 - 项目类别:
ANALYSIS OF A NON-TUMORIGENIC TERATOCARCINOMA CELL LINE
非致瘤性畸胎癌细胞系的分析
- 批准号:
3193573 - 财政年份:1990
- 资助金额:
$ 28.1万 - 项目类别:














{{item.name}}会员




